ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.20
      0.91%
      US Tech 100
      17,174.80
      0.58%
      Dow Jones
      38,225.66
      0.85%
      Brent Oil
      83.54
      -0.11%
      Bitcoin
      59,512.31
      0.66%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pulse Biosciences Inc (PLSE)

      7. Pulse Biosciences Inc (PLSE) News

      PLSE

      Pulse Biosciences (PLSE)

      Pulse Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PLSE
      DateTimeSourceHeadlineSymbolCompany
      2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      05/02/20248:00AMBusiness WirePulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
      04/24/20244:05PMBusiness WirePulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024NASDAQ:PLSEPulse Biosciences Inc
      03/28/20244:12PMBusiness WirePulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
      03/28/20244:10PMBusiness WirePulse Biosciences Announces Plans to Initiate a Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
      03/14/20244:05PMBusiness WirePulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024NASDAQ:PLSEPulse Biosciences Inc
      03/11/20249:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      03/08/20241:17PMBusiness WirePulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
      02/14/20249:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      02/14/20248:00AMBusiness WirePulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility StudyNASDAQ:PLSEPulse Biosciences Inc
      01/31/20248:00AMBusiness WirePulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF SymposiumNASDAQ:PLSEPulse Biosciences Inc
      01/09/20249:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      01/02/20249:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      01/02/20248:00AMBusiness WirePulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac ClampNASDAQ:PLSEPulse Biosciences Inc
      12/22/20239:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      12/20/20239:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      12/20/20238:00AMBusiness WirePulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac CatheterNASDAQ:PLSEPulse Biosciences Inc
      11/27/20235:29PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PLSEPulse Biosciences Inc
      11/27/20239:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      11/21/20239:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      11/21/20238:00AMBusiness WirePulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous ElectrodeNASDAQ:PLSEPulse Biosciences Inc
      11/17/20239:11AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      11/17/20239:10AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      11/15/20234:05PMBusiness WirePulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:PLSEPulse Biosciences Inc
      11/13/20235:21PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PLSEPulse Biosciences Inc
      11/13/20235:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLSEPulse Biosciences Inc
      11/13/20239:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      11/13/20238:00AMBusiness WirePulse Biosciences Reports Business Updates and Third Quarter 2023 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
      11/10/20234:56PMBusiness WireUPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference CallNASDAQ:PLSEPulse Biosciences Inc
      11/03/20235:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:PLSE